Susquehanna International Group, LLP Igm Biosciences, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$6.05 - $17.83 $95,590 - $281,714
-15,800 Reduced 33.98%
30,700 $187,000
Q3 2024

Nov 14, 2024
BUY
$6.28 - $17.68 $212,892 - $599,352
33,900 Added 269.05%
46,500 $769,000
Q2 2024

Aug 15, 2024
BUY
$6.51 - $11.47 $82,026 - $144,522
12,600 New
12,600 $86,000
Q2 2023

Aug 11, 2023
BUY
$8.86 - $14.0 $142,646 - $225,400
16,100 New
16,100 $148,000

Others Institutions Holding IGMS

# of Institutions
68
Shares Held
15.1M
Call Options Held
0
Put Options Held
0
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $36.8M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email